Recurrence of HCC After LDLT Clinical Trial
Official title:
Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits
Within community with high incidence of HCC, stretching the limits could be justified based on tumor characters and its biological behavior
590 Egyptian patients underwent LDLT; of them, 172 (32%) patients were transplanted for HCC. Twenty six cases (15.1%) were excluded due to early postoperative mortality (n=22) or due to non HCC related mortality (n=4). One hundred forty six patients were retrospectively reviewed to determine prognostic factors for recurrence. ;
Observational Model: Case-Crossover, Time Perspective: Retrospective